Skip to content
10-K

Annual Report

PROTECT PHARMACEUTICAL Corp

0001493152-19-002214

← back to feed
Filed
Feb 19, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2017 · Dec 31, 2017 1.2M sh
Shares Diluted FY 2017 · Dec 31, 2016 1.11M sh
Shares Outstanding FY 2017 · Dec 31, 2017 1.11M sh
Stockholders Equity FY 2017 · Dec 31, 2017 −$143.44K
Stockholders Equity FY 2017 · Dec 31, 2016 −$20.83K
Stockholders Equity restated FY 2017 · Dec 31, 2015 −$100.45K
Current Liabilities FY 2017 · Dec 31, 2017 $42.44K
Current Liabilities FY 2017 · Dec 31, 2016 $20.83K
Total Liabilities FY 2017 · Dec 31, 2017 $143.44K
Total Liabilities FY 2017 · Dec 31, 2016 $20.83K
Total Assets FY 2017 · Dec 31, 2017 $0
Total Assets FY 2017 · Dec 31, 2016 $0
Eps Diluted FY 2017 · Dec 31, 2017 −$0.10
Eps Diluted FY 2017 · Dec 31, 2016 −$0.04
Eps Basic FY 2017 · Dec 31, 2017 −$0.11
Eps Basic FY 2017 · Dec 31, 2016 −$0.04
Sga Expense FY 2017 · Dec 31, 2017 $200
Sga Expense FY 2017 · Dec 31, 2016 $332
Net Income FY 2017 · Dec 31, 2017 −$122.61K
Net Income FY 2017 · Dec 31, 2016 −$41.71K
Operating Income FY 2017 · Dec 31, 2017 −$115.4K
Operating Income FY 2017 · Dec 31, 2016 −$41.71K
Operating Cash Flow FY 2017 · Dec 31, 2016 −$14.16K